文献速递糖尿病肥胖与代谢综合征

脂解相关多基因风险评分决定内脏脂肪量与胰岛素原转化

A Polygenic Risk Score of Lipolysis-Increasing Alleles Determines Visceral Fat Mass and Proinsulin Conversion.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

在2789名无糖尿病的图宾根家族研究参与者中,基于48个脂解相关基因的常见SNP构建多基因风险评分,发现由6个基因SNP组成的评分与血浆游离脂肪酸和甘油水平、内脏脂肪量及胰岛素原转化相关;脂解增加等位基因越多,内脏脂肪量越低、胰岛素原转化越低。

要点

  • 脂解相关SNP评分与血浆游离脂肪酸和甘油水平显著关联。
  • 脂解增加等位基因越多,内脏脂肪量越低。
  • 脂解增加等位基因越多,胰岛素原转化越低。

核心结论

  • 常见SNP构成的脂解遗传评分可决定较低的内脏脂肪量和较低的胰岛素原转化。

研究设计与样本

  • 图宾根2型糖尿病家族研究,纳入最多2789名无糖尿病参与者,行口服葡萄糖耐量试验,其中942人有磁共振体脂测量。

主要发现

  • 10个基因的SNP与血浆游离脂肪酸名义关联(P<0.05),7个与甘油关联,6个与两者均关联,均独立于胰岛素敏感性。
  • 由ADCY4、CIDEA、GNAS、PDE8B、PRKAA1、PRKAG2的SNP组成的评分与血浆FFA和甘油测量关联(1.4*10-9 ≤ P ≤ 1.2*10-5)。
  • 该评分与内脏脂肪量关联(P=0.0326),与胰岛素原转化关联(P≤0.0272)。

关键数值与推荐

  • 脂解增加等位基因越多,内脏脂肪量越低,胰岛素原转化越低。

临床怎么用

  • 脂解相关遗传评分有助于识别内脏脂肪分布和胰岛素原转化异常风险较高的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary dysregulation of adipose tissue lipolysis caused by genetic variation and independent of insulin resistance could explain unhealthy body fat distribution and its metabolic consequences. OBJECTIVE: To analyze common single nucleotide polymorphisms (SNPs) in 48 lipolysis-, but not insulin-signaling-related genes, to form polygenic risk scores of lipolysis-associated SNPs, and to investigate their effects on body fat distribution, glycemia, insulin sensitivity, insulin secretion, and proinsulin conversion. STUDY DESIGN, PARTICIPANTS, AND METHODS: SNP array, anthropometric, and metabolic data were available from up to 2789 participants without diabetes of the Tübingen Family study of type 2 diabetes characterized by oral glucose tolerance tests. In a subgroup (n = 942), magnetic resonance measurements of body fat stores were available. RESULTS: We identified insulin-sensitivity-independent nominal associations (P < 0.05) of SNPs in 10 genes with plasma free fatty acids (FFAs), in 7 genes with plasma glycerol and in 6 genes with both, plasma FFAs and glycerol. A score formed of the latter SNPs (in ADCY4, CIDEA, GNAS, PDE8B, PRKAA1, PRKAG2) was associated with plasma FFA and glycerol measurements (1.4*10-9 ≤ P ≤ 1.2*10-5), visceral adipose tissue mass (P = 0.0326), and proinsulin conversion (P ≤ 0.0272). The more lipolysis-increasing alleles a subject had, the lower was the visceral fat mass and the lower the proinsulin conversion. CONCLUSIONS: We found evidence for a genetic basis of adipose tissue lipolysis resulting from common SNPs in CIDEA, AMP-activated protein kinase subunits, and cAMP signaling components. A genetic score of lipolysis-increasing alleles determined lower visceral fat mass and lower proinsulin conversion.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kempe-Teufel D, Machicao F, Machann J, et al. A Polygenic Risk Score of Lipolysis-Increasing Alleles Determines Visceral Fat Mass and Proinsulin Conversion. J Clin Endocrinol Metab. 2019. PMID: 30649496. doi:10.1210/jc.2018-02042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。